Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multi-centre, randomized, double-blind, placebo-controlled, parallel-group, multiple oral dose study to assess the efficacy, safety and tolerability of AQW051 in reducing L-dopa induced dyskinesias in Parkinson's patients with moderate to severe L-dopa induced dyskinesias

Next Previous
X
Search
Trial Profile

A multi-centre, randomized, double-blind, placebo-controlled, parallel-group, multiple oral dose study to assess the efficacy, safety and tolerability of AQW051 in reducing L-dopa induced dyskinesias in Parkinson's patients with moderate to severe L-dopa induced dyskinesias

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 01 Mar 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs VQW 765 (Primary)
  • Indications Drug-induced dyskinesia; Parkinson's disease
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Novartis

    • Most Recent Events

    • 15 Mar 2016 Primary endpoint has not been met. (Change in Unified Parkinsons Disease Rating Scale (UPDRS) - Part III score [ Time Frame: Baseline, Day 28 ] [ Designated as safety issue: No ]), according to results published in the Movement Disorders
    • 15 Mar 2016 Primary endpoint has not been met. (Change in Modified Abnormal Involuntary Movement Scale (mAIMS)score [ Time Frame: Baseline, Day 28 ] [ Designated as safety issue: No ]),according to the results published in the Movement Disorders.
    • 15 Mar 2016 Results published in the Movement Disorders

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top